| Primary |
| Infantile Spasms |
35.4% |
| Product Used For Unknown Indication |
16.7% |
| Epilepsy |
15.0% |
| Convulsion |
10.7% |
| Complex Partial Seizures |
7.8% |
| Drug Use For Unknown Indication |
2.9% |
| Partial Seizures |
2.9% |
| Grand Mal Convulsion |
2.0% |
| Vitamin Supplementation |
1.5% |
| Tuberous Sclerosis |
1.2% |
| Temporal Lobe Epilepsy |
0.9% |
| Anxiety |
0.4% |
| Lennox-gastaut Syndrome |
0.4% |
| Muscle Spasms |
0.4% |
| Headache |
0.3% |
| Insomnia |
0.3% |
| Simple Partial Seizures |
0.3% |
| Sinus Headache |
0.3% |
| Anxiety Disorder |
0.2% |
| Compulsions |
0.2% |
|
| Death |
29.1% |
| Convulsion |
10.3% |
| Drug Ineffective |
6.8% |
| Retinal Disorder |
6.3% |
| Somnolence |
6.3% |
| Retinogram Abnormal |
5.4% |
| Visual Field Defect |
5.1% |
| Respiratory Distress |
3.7% |
| Grand Mal Convulsion |
3.4% |
| Vomiting |
2.8% |
| Surgery |
2.6% |
| Urinary Tract Infection |
2.6% |
| Pneumonia |
2.3% |
| Tremor |
2.3% |
| Brain Operation |
2.0% |
| Fall |
2.0% |
| Visual Acuity Reduced |
2.0% |
| Blindness |
1.7% |
| Lethargy |
1.7% |
| Respiratory Failure |
1.7% |
|
| Secondary |
| Epilepsy |
24.3% |
| Infantile Spasms |
22.0% |
| Convulsion |
14.3% |
| Product Used For Unknown Indication |
8.3% |
| Complex Partial Seizures |
8.0% |
| Vitamin Supplementation |
6.7% |
| Insomnia |
2.0% |
| Anxiety |
1.8% |
| Urinary Tract Infection |
1.4% |
| Headache |
1.3% |
| Pharyngitis Streptococcal |
1.3% |
| Drug Use For Unknown Indication |
1.3% |
| Sinus Headache |
1.2% |
| Tonic Convulsion |
1.2% |
| Hypertension |
1.1% |
| Depression |
0.9% |
| Lennox--gastaut Syndrome |
0.9% |
| Tuberous Sclerosis |
0.9% |
| Pain |
0.7% |
| Compulsions |
0.6% |
|
| Convulsion |
15.0% |
| Tonic Convulsion |
13.6% |
| Postictal State |
11.6% |
| Vomiting |
8.2% |
| Somnolence |
5.4% |
| Dehydration |
4.1% |
| Irritability |
4.1% |
| Pancytopenia |
4.1% |
| Urinary Tract Infection |
4.1% |
| Visual Impairment |
4.1% |
| Death |
3.4% |
| Partial Seizures With Secondary Generalisation |
3.4% |
| Pneumonia Aspiration |
3.4% |
| Sudden Unexplained Death In Epilepsy |
3.4% |
| Mood Swings |
2.7% |
| Rash Pruritic |
2.7% |
| Sepsis |
2.0% |
| Toxicity To Various Agents |
2.0% |
| Abdominal Pain Upper |
1.4% |
| Grand Mal Convulsion |
1.4% |
|
| Concomitant |
| Epilepsy |
26.9% |
| Tuberous Sclerosis |
13.4% |
| Product Used For Unknown Indication |
10.4% |
| Convulsion |
8.3% |
| Unevaluable Event |
6.3% |
| Astrocytoma |
6.0% |
| Convulsions |
5.6% |
| Astrocytoma, Low Grade |
3.0% |
| Blood Pressure |
2.8% |
| Lymphangioleiomyomatosis |
2.8% |
| Primary Hypothyroidism |
2.8% |
| Hypothyroidism |
2.1% |
| Prophylaxis |
1.6% |
| Asthma |
1.4% |
| Contraception |
1.4% |
| Tsh Decreased |
1.4% |
| Constipation |
1.2% |
| Gastritis |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Grand Mal Convulsion |
0.9% |
|
| Convulsion |
11.4% |
| Epilepsy |
11.4% |
| Cough |
10.1% |
| Vomiting |
10.1% |
| Somnolence |
6.3% |
| Drug Ineffective |
5.1% |
| Grand Mal Convulsion |
3.8% |
| Mouth Ulceration |
3.8% |
| Nasopharyngitis |
3.8% |
| Pyrexia |
3.8% |
| Shock |
3.8% |
| Sinusitis |
3.8% |
| Status Epilepticus |
3.8% |
| Thrombocytopenia |
3.8% |
| Affective Disorder |
2.5% |
| Arthralgia |
2.5% |
| Arthropathy |
2.5% |
| Condition Aggravated |
2.5% |
| Dermatitis Contact |
2.5% |
| Disorientation |
2.5% |
|
| Interacting |
| Bronchopulmonary Dysplasia |
25.0% |
| Epilepsy |
25.0% |
| Infantile Spasms |
25.0% |
| Product Used For Unknown Indication |
25.0% |
|
| Convulsion |
50.0% |
| Rhabdomyolysis |
50.0% |
|
